Publications by authors named "Terrence Cescon"

Claim this Profile
N
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi, Terrence P Cescon

Neurooncol Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
Maysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong, Terrence Cescon

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer.
Yanin Chávarri-Guerra, Catherine A Marcum, Carolyn B Hendricks, Deborah Wilbur, Terrence Cescon

J Geriatr Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Andrew M Evens, Fangxin Hong, Thomas M Habermann, Ranjana H Advani, Randy D Gascoyne, Terrence P Cescon

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M Abu-Khalaf, Terrence P Cescon

Breast Cancer Res Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer.
Andre Konski, Joshua E Meyer, Michael Joiner, Michael J Hall, Philip Philip, Terrence P Cescon

Radiother Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Susan V Montgomery, Andrea M Barsevick, Brian L Egleston, Ruth Bingler, Karen Ruth, Terrence P Cescon

Fam Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Jeffrey R Infante, Tony R Reid, Allen L Cohn, William J Edenfield, Terrence P Cescon

Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial.
John D Hainsworth, David R Spigel, Bobby L Clark, Dianna Shipley, Dana S Thompson, Terrence Cescon

Cancer J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intention to communicate BRCA1/BRCA2 genetic test results to the family.
Andrea M Barsevick, Susan V Montgomery, Karen Ruth, Eric A Ross, Brian L Egleston, Terrence P Cescon

J Fam Psychol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer.
Sheri K Dennison, Samuel A Jacobs, John W Wilson, Janell Seeger, Terrence P Cescon

Invest New Drugs· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer risk assessment program: a 10-year update of cancer detection.
Veda N Giri, Jennifer Beebe-Dimmer, Mark Buyyounouski, Andre Konski, Steven J Feigenberg, Terrence Cescon

J Urol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.
James N Atkins, Samuel A Jacobs, H Samuel Wieand, Roy E Smith, William J John, Terrence P Cescon

Clin Colorectal Cancer· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis